İLHAN, M. S. Et Al. 2022. Newly Synthesized Benzimidazoles Inhibit Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 and-9 Levels in Prostate Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry , vol.22, no.11 , 2109-2115.

İLHAN, M. S., Dilekci, G., Guner, A., & Bektas, H., (2022). Newly Synthesized Benzimidazoles Inhibit Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 and-9 Levels in Prostate Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry , vol.22, no.11, 2109-2115.

İLHAN, MUHAMMED Et Al. "Newly Synthesized Benzimidazoles Inhibit Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 and-9 Levels in Prostate Cancer Cells," Anti-Cancer Agents in Medicinal Chemistry , vol.22, no.11, 2109-2115, 2022

İLHAN, MUHAMMED S. Et Al. "Newly Synthesized Benzimidazoles Inhibit Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 and-9 Levels in Prostate Cancer Cells." Anti-Cancer Agents in Medicinal Chemistry , vol.22, no.11, pp.2109-2115, 2022

İLHAN, M. S. Et Al. (2022) . "Newly Synthesized Benzimidazoles Inhibit Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 and-9 Levels in Prostate Cancer Cells." Anti-Cancer Agents in Medicinal Chemistry , vol.22, no.11, pp.2109-2115.

@article{article, author={MUHAMMED SÜLEYMAN İLHAN Et Al. }, title={Newly Synthesized Benzimidazoles Inhibit Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 and-9 Levels in Prostate Cancer Cells}, journal={Anti-Cancer Agents in Medicinal Chemistry}, year=2022, pages={2109-2115} }